189 related articles for article (PubMed ID: 9925575)
1. Staphylokinase as a plasminogen activator component in recombinant fusion proteins.
Szarka SJ; Sihota EG; Habibi HR; Wong S
Appl Environ Microbiol; 1999 Feb; 65(2):506-13. PubMed ID: 9925575
[TBL] [Abstract][Full Text] [Related]
2. Role of the N-terminal region of staphylokinase (SAK): evidence for the participation of the N-terminal region of SAK in the enzyme-substrate complex formation.
Rajamohan G; Dikshit KL
FEBS Lett; 2000 Jun; 474(2-3):151-8. PubMed ID: 10838076
[TBL] [Abstract][Full Text] [Related]
3. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity--a staphylokinase variant. I. In vitro study.
Szemraj J; Walkowiak B; Kawecka I; Janiszewska G; Buczko W; Bartkowiak J; Chabielska E
J Thromb Haemost; 2005 Oct; 3(10):2156-65. PubMed ID: 16150047
[TBL] [Abstract][Full Text] [Related]
4. Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent - a staphylokinase variant.
Kowalski M; Brown G; Bieniasz M; Oszajca K; Chabielska E; Pietras T; Szemraj Z; Makandjou-Ola E; Bartkowiak J; Szemraj J
Acta Biochim Pol; 2009; 56(1):41-53. PubMed ID: 19018330
[TBL] [Abstract][Full Text] [Related]
5. Staphylokinase requires NH2-terminal proteolysis for plasminogen activation.
Schlott B; Gührs KH; Hartmann M; Röcker A; Collen D
J Biol Chem; 1997 Feb; 272(9):6067-72. PubMed ID: 9038231
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of a novel staphylokinase variant with thrombin-inhibitory activity.
Wang M; Wang Y; Wang J; Zou M; Liu S; Xu T; Cai X; Wu C; Wang J; Xu D
Biotechnol Lett; 2009 Dec; 31(12):1923-7. PubMed ID: 19685208
[TBL] [Abstract][Full Text] [Related]
7. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.
Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T
J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091
[TBL] [Abstract][Full Text] [Related]
8. Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26.
Schlott B; Hartmann M; Gührs KH; Birch-Hirschfeld E; Gase A; Vettermann S; Collen D; Lijnen HR
Biochim Biophys Acta; 1994 Feb; 1204(2):235-42. PubMed ID: 8142464
[TBL] [Abstract][Full Text] [Related]
9. Modular design of a novel chimeric protein with combined thrombin inhibitory activity and plasminogen-activating potential.
Wirsching F; Luge C; Schwienhorst A
Mol Genet Metab; 2002 Mar; 75(3):250-9. PubMed ID: 11914037
[TBL] [Abstract][Full Text] [Related]
10. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
[TBL] [Abstract][Full Text] [Related]
11. Novel self-cleavage activity of Staphylokinase fusion proteins: An interesting finding and its possible applications.
Prasad B; Salunkhe SS; Padmanabhan S
Protein Expr Purif; 2010 Feb; 69(2):191-7. PubMed ID: 19638310
[TBL] [Abstract][Full Text] [Related]
12. Role of the kringle domain in plasminogen activation with staphylokinase.
Arai K; Madoiwa S; Mimuro J; Asakura S; Matsuda M; Sako T; Sakata Y
J Biochem; 1998 Jan; 123(1):71-7. PubMed ID: 9504411
[TBL] [Abstract][Full Text] [Related]
13. Pro42 and Val45 of staphylokinase modulate intermolecular interactions of His43-Tyr44 pair and specificity of staphylokinase-plasmin activator complex.
Singh S; Ashish ; Dikshit KL
FEBS Lett; 2012 Mar; 586(6):653-8. PubMed ID: 22321644
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of the bacterial plasminogen activator staphylokinase secreted by a recombinant Bacillus subtilis.
Gerlach D; Kraft R; Behnke D
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):314-22. PubMed ID: 3146168
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
Sakai M; Watanuki M; Matsuo O
Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional basis of plasminogen activation by staphylokinase.
Jespers L; Vanwetswinkel S; Lijnen HR; Van Herzeele N; Van Hoef B; Demarsin E; Collen D; De Maeyer M
Thromb Haemost; 1999 Apr; 81(4):479-85. PubMed ID: 10235424
[TBL] [Abstract][Full Text] [Related]
17. C-terminal lysine residues enhance plasminogen activation by inducing conformational flexibility and stabilization of activator complex of staphylokinase with plasmin.
Kaur P; Sethi D; Hade MD; Kaur J; Dikshit KL
Arch Biochem Biophys; 2023 Jul; 743():109671. PubMed ID: 37336343
[TBL] [Abstract][Full Text] [Related]
18. Guiding a docking mode by phage display: selection of correlated mutations at the staphylokinase-plasmin interface.
Jespers L; Lijnen HR; Vanwetswinkel S; Van Hoef B; Brepoels K; Collen D; De Maeyer M
J Mol Biol; 1999 Jul; 290(2):471-9. PubMed ID: 10390345
[TBL] [Abstract][Full Text] [Related]
19. NH2-terminal structural motifs in staphylokinase required for plasminogen activation.
Schlott B; Gührs KH; Hartmann M; Röcker A; Collen D
J Biol Chem; 1998 Aug; 273(35):22346-50. PubMed ID: 9712854
[TBL] [Abstract][Full Text] [Related]
20. Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur.
Grella DK; Castellino FJ
Blood; 1997 Mar; 89(5):1585-9. PubMed ID: 9057640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
